Mixing Pens and the Future of Diabetes Drugs
With the availability of a smaller mixing pen, mass marketing of less stable medications is possible. Bidureon is one such medication, and the properties of its pen are discussed along with the prospects for future mixing pens.
Gespeichert in:
| Veröffentlicht in: | Journal of diabetes science and technology 2015-07, Vol.9 (4), p.822-823 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 823 |
|---|---|
| container_issue | 4 |
| container_start_page | 822 |
| container_title | Journal of diabetes science and technology |
| container_volume | 9 |
| creator | Ginsberg, Barry H. |
| description | With the availability of a smaller mixing pen, mass marketing of less stable medications is possible. Bidureon is one such medication, and the properties of its pen are discussed along with the prospects for future mixing pens. |
| doi_str_mv | 10.1177/1932296815585873 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4525653</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1932296815585873</sage_id><sourcerecordid>1693187546</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3493-116ec4c48fc002085ff3ee24e7b75eea0ed984a7b654f650bec8ab734950d5a83</originalsourceid><addsrcrecordid>eNp1kM1Lw0AQxRdRbK3ePUmOHozuZj9zEaS1KlT0oOdls5mkKemm7iai_70prUUFTzPMvPeb4SF0SvAlIVJekZQmSSoU4VxxJekeGq5H8Xq2_6MfoKMQFhhzpqQ8RIOEp4ypVAzRxWP1UbkyegYXIuPyqJ1DNO3azkPUFNGkMhm0EKKJ78pwjA4KUwc42dYRep3evozv49nT3cP4ZhZbylIaEyLAMstUYTFOsOJFQQESBjKTHMBgyFPFjMwEZ4XgOAOrTCZ7L8c5N4qO0PWGu-qyJeQWXOtNrVe-Whr_qRtT6d8bV8112bxrxhMuOO0B51uAb946CK1eVsFCXRsHTRc0ESklSnImeineSK1vQvBQ7M4QrNch678h95azn-_tDN-p9oJ4IwimBL1oOu_6uP4HfgH-b4OV</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1693187546</pqid></control><display><type>article</type><title>Mixing Pens and the Future of Diabetes Drugs</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>SAGE Complete A-Z List</source><source>PubMed Central</source><creator>Ginsberg, Barry H.</creator><creatorcontrib>Ginsberg, Barry H.</creatorcontrib><description>With the availability of a smaller mixing pen, mass marketing of less stable medications is possible. Bidureon is one such medication, and the properties of its pen are discussed along with the prospects for future mixing pens.</description><identifier>ISSN: 1932-2968</identifier><identifier>EISSN: 1932-2968</identifier><identifier>EISSN: 1932-3107</identifier><identifier>DOI: 10.1177/1932296815585873</identifier><identifier>PMID: 25944896</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Diabetes Mellitus, Type 2 - blood ; Diabetes Mellitus, Type 2 - drug therapy ; Humans ; Hyperglycemia - drug therapy ; Injections, Subcutaneous - instrumentation ; Original ; Peptides - administration & dosage ; Syringes ; Venoms - administration & dosage</subject><ispartof>Journal of diabetes science and technology, 2015-07, Vol.9 (4), p.822-823</ispartof><rights>2015 Diabetes Technology Society</rights><rights>2015 Diabetes Technology Society.</rights><rights>2015 Diabetes Technology Society 2015 Diabetes Technology Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3493-116ec4c48fc002085ff3ee24e7b75eea0ed984a7b654f650bec8ab734950d5a83</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525653/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525653/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,21799,27903,27904,43600,43601,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25944896$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ginsberg, Barry H.</creatorcontrib><title>Mixing Pens and the Future of Diabetes Drugs</title><title>Journal of diabetes science and technology</title><addtitle>J Diabetes Sci Technol</addtitle><description>With the availability of a smaller mixing pen, mass marketing of less stable medications is possible. Bidureon is one such medication, and the properties of its pen are discussed along with the prospects for future mixing pens.</description><subject>Diabetes Mellitus, Type 2 - blood</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Humans</subject><subject>Hyperglycemia - drug therapy</subject><subject>Injections, Subcutaneous - instrumentation</subject><subject>Original</subject><subject>Peptides - administration & dosage</subject><subject>Syringes</subject><subject>Venoms - administration & dosage</subject><issn>1932-2968</issn><issn>1932-2968</issn><issn>1932-3107</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kM1Lw0AQxRdRbK3ePUmOHozuZj9zEaS1KlT0oOdls5mkKemm7iai_70prUUFTzPMvPeb4SF0SvAlIVJekZQmSSoU4VxxJekeGq5H8Xq2_6MfoKMQFhhzpqQ8RIOEp4ypVAzRxWP1UbkyegYXIuPyqJ1DNO3azkPUFNGkMhm0EKKJ78pwjA4KUwc42dYRep3evozv49nT3cP4ZhZbylIaEyLAMstUYTFOsOJFQQESBjKTHMBgyFPFjMwEZ4XgOAOrTCZ7L8c5N4qO0PWGu-qyJeQWXOtNrVe-Whr_qRtT6d8bV8112bxrxhMuOO0B51uAb946CK1eVsFCXRsHTRc0ESklSnImeineSK1vQvBQ7M4QrNch678h95azn-_tDN-p9oJ4IwimBL1oOu_6uP4HfgH-b4OV</recordid><startdate>20150701</startdate><enddate>20150701</enddate><creator>Ginsberg, Barry H.</creator><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150701</creationdate><title>Mixing Pens and the Future of Diabetes Drugs</title><author>Ginsberg, Barry H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3493-116ec4c48fc002085ff3ee24e7b75eea0ed984a7b654f650bec8ab734950d5a83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Diabetes Mellitus, Type 2 - blood</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Humans</topic><topic>Hyperglycemia - drug therapy</topic><topic>Injections, Subcutaneous - instrumentation</topic><topic>Original</topic><topic>Peptides - administration & dosage</topic><topic>Syringes</topic><topic>Venoms - administration & dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ginsberg, Barry H.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of diabetes science and technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ginsberg, Barry H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mixing Pens and the Future of Diabetes Drugs</atitle><jtitle>Journal of diabetes science and technology</jtitle><addtitle>J Diabetes Sci Technol</addtitle><date>2015-07-01</date><risdate>2015</risdate><volume>9</volume><issue>4</issue><spage>822</spage><epage>823</epage><pages>822-823</pages><issn>1932-2968</issn><eissn>1932-2968</eissn><eissn>1932-3107</eissn><abstract>With the availability of a smaller mixing pen, mass marketing of less stable medications is possible. Bidureon is one such medication, and the properties of its pen are discussed along with the prospects for future mixing pens.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>25944896</pmid><doi>10.1177/1932296815585873</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1932-2968 |
| ispartof | Journal of diabetes science and technology, 2015-07, Vol.9 (4), p.822-823 |
| issn | 1932-2968 1932-2968 1932-3107 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4525653 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; SAGE Complete A-Z List; PubMed Central |
| subjects | Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - drug therapy Humans Hyperglycemia - drug therapy Injections, Subcutaneous - instrumentation Original Peptides - administration & dosage Syringes Venoms - administration & dosage |
| title | Mixing Pens and the Future of Diabetes Drugs |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T13%3A55%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mixing%20Pens%20and%20the%20Future%20of%20Diabetes%20Drugs&rft.jtitle=Journal%20of%20diabetes%20science%20and%20technology&rft.au=Ginsberg,%20Barry%20H.&rft.date=2015-07-01&rft.volume=9&rft.issue=4&rft.spage=822&rft.epage=823&rft.pages=822-823&rft.issn=1932-2968&rft.eissn=1932-2968&rft_id=info:doi/10.1177/1932296815585873&rft_dat=%3Cproquest_pubme%3E1693187546%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1693187546&rft_id=info:pmid/25944896&rft_sage_id=10.1177_1932296815585873&rfr_iscdi=true |